Carregant...

Cancer immunotherapy: exploiting neoepitopes

The efficacy of cancer vaccines has long been hampered by insufficient definition of tumor-specific antigens. A recent study by Kreiter et al. published in Nature has provided a blueprint for a patient-tailored approach to develop individualized RNA vaccines.

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Res
Autors principals: Platten, Michael, Offringa, Rienk
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4528051/
https://ncbi.nlm.nih.gov/pubmed/26032267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2015.66
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!